Floridienne (FLOB) Q3 2024 TU earnings summary

Executive summary

• Achieved strong growth in results as of September 2024, driven by historical activities and successful BIOTROP integration.

• Sales reached EUR 502.4 million, up 25% year-over-year.

• EBITDA rose to EUR 84.9 million, an increase of EUR 35.9 million compared to the previous year.

• Net result stood at EUR 17.1 million, up EUR 8.0 million year-over-year.

Segment performance

• Life Sciences (BioFirst) saw substantial operating growth, especially in greenhouse crops and with BIOTROP's integration.

• Food Division experienced sales growth and improved EBITDA, aided by cold sauces in retail and exports.

• Chemicals Division reported declines in turnover and EBITDA due to weak recycled metal prices and a fire at a SNAM storage site.

• Kimflor maintained performance despite reduced demand from Turkey's tighter monetary policy.

Significant events and developments

• BIOTROP integration continued successfully, posting record turnover and profitability in Q3.

• Fire at SNAM storage site assessed, with limited financial impact due to insurance.